Otto Dawn Parsell 4
4 · Tricida, Inc. · Filed Sep 14, 2020
Insider Transaction Report
Form 4
Tricida, Inc.TCDA
Otto Dawn Parsell
Sr VP, Clinical Development
Transactions
- Award
Common Stock
2020-09-10+4,000→ 4,637 total
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") that vest on December 31, 2021, subject to the Reporting Person's continuous service through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock.
- [F2]This amount includes 382 shares acquired on June 30, 2020 under the Tricida, Inc. 2018 Employee Stock Purchase Plan. This acquisition is exempt from Section 16(b) pursuant to Rule 16b-3(c) and exempt from Section 16(a) pursuant to Rule 16a-3(f)(1)(i)(B).